M1002
CAS No. 823830-85-9
M1002( —— )
Catalog No. M35596 CAS No. 823830-85-9
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist that enhances the affinity of HIF-2alpha and ARNT for transcriptional activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 362 | In Stock |
|
| 100MG | 533 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1107 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameM1002
-
NoteResearch use only, not for human use.
-
Brief DescriptionM1002 is a hypoxia-inducible factor-2 (HIF-2) agonist that enhances the affinity of HIF-2alpha and ARNT for transcriptional activation.
-
DescriptionM1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors.
-
In VitroM1002 (10 μM; 24 h) enhances the expression of HIF-2 target genes with great efficacy.M1002 (5 μM; 24 h) treatment shows synergy with prolyl hydroxylase domain (PHD) inhibitors.RT-PCR Cell Line:786-O cells Concentration:10 μM Incubation Time:24 hoursResult:Showed clear agonistic effects on the expression of HIF-2 target genes in 786-O cells as compared with the control.RT-PCR Cell Line:Hep3B cells Concentration:5 μM Incubation Time:24 hours Result:Elevated the expression of EPO and NDRG1 by co-treatment of M1002 together with PHD inhibitors, compared with M1002 alone treatment.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number823830-85-9
-
Formula Weight394.29
-
Molecular FormulaC15H8F6N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (126.81 mM; Ultrasonic (<60°C); )DMF : 50 mg/mL (126.81 mM; Ultrasonic)
-
SMILESFC(F)(F)C1=CC(=CC(NC2=NS(=O)(=O)C3=CC=CC=C23)=C1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dalei Wu, et al. Bidirectional modulation of HIF-2 activity through chemical ligands. Nat Chem Biol. 2019 Apr;15(4):367-376.?
molnova catalog
related products
-
Belzutifan
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM).
-
HIF1-IN-2
A potent, selective HIF-1 inhibitor with IC50 of 1.9 nM, with no signigicant inhibition on HSF and NF-κB.
-
Molidustat
Molidustat (BAY 85-3934) is an orally active small molecule inhibitor of hypoxia inducible factor prolyl hydroxylase (HIF-PH) with IC50 of 480 nM, 280 nM and 450 nM for PHD1, PHD2, and PHD3, respectively.
Cart
sales@molnova.com